Advanced Clinical Reports

A scientific/medical skill for writing structured clinical reports — medical documentation that meets regulatory, legal, and clinical standards. Advanced Clinical Reports guides the creation of case reports, clinical study reports, adverse event narratives, and medical summaries with precision and compliance.

When to Use This Skill

Choose Advanced Clinical Reports when:

• Writing clinical case reports for journal submission
• Creating clinical study reports (CSRs) for regulatory submission
• Documenting adverse event narratives for pharmacovigilance
• Preparing medical summaries for institutional review boards

Consider alternatives when:

• You need real-time clinical documentation (use EHR templates)
• You need clinical trial protocol writing (use protocol-specific tools)
• You want patient-facing health information (use health literacy tools)

Quick Start

Copy
claude "Write a clinical case report structure for a rare adverse drug reaction"

Copy
# Clinical Case Report: [Title]

## Abstract
**Background:** [Disease context and clinical relevance]
**Case Presentation:** [Summary of key findings]
**Conclusions:** [Clinical significance and lessons learned]

## Introduction
- Disease epidemiology and incidence
- Current treatment landscape
- Rationale for reporting this case (novelty, clinical impact)

## Case Presentation

### Patient Demographics
| Parameter | Value |
|-----------|-------|
| Age | XX years |
| Sex | Male/Female |
| Ethnicity | [Self-reported] |
| Relevant PMH | [Pertinent medical history] |

### Timeline
| Day | Event | Assessment |
|-----|-------|-----------|
| 0 | Drug initiated | Baseline labs normal |
| 7 | Symptom onset | [Describe presentation] |
| 10 | Drug discontinued | Adverse reaction suspected |
| 14 | Resolution | Symptoms resolved |

### Diagnostic Workup
[Relevant lab results, imaging, pathology]

### Treatment and Outcome
[Intervention, response, follow-up]

## Discussion
- Mechanism of adverse reaction
- Literature comparison (similar cases)
- Naranjo causality assessment score
- Clinical implications

## Patient Perspective
[If applicable — patient consent obtained]

## References
[Numbered Vancouver style]

Core Concepts

Clinical Report Types

Type	Purpose	Standard
Case Report	Document unusual clinical observations	CARE guidelines
Clinical Study Report	Summarize trial results for regulators	ICH E3
Adverse Event Narrative	Document individual safety events	CIOMS form
Medical Summary	Synthesize patient medical history	Institution-specific
Systematic Review	Aggregate evidence across studies	PRISMA guidelines

Causality Assessment (Naranjo Scale)

Copy
## Naranjo Adverse Drug Reaction Probability Scale

| Question | Yes | No | Unknown |
|----------|-----|-----|---------|
| Previous reports of this reaction? | +1 | 0 | 0 |
| ADR appeared after drug given? | +2 | -1 | 0 |
| ADR improved on discontinuation? | +1 | 0 | 0 |
| ADR reappeared on rechallenge? | +2 | -1 | 0 |
| Alternative causes excluded? | -1 | +2 | 0 |
| ADR with placebo? | -1 | +1 | 0 |
| Drug detected in toxic concentrations? | +1 | 0 | 0 |
| Dose-response relationship? | +1 | 0 | 0 |
| Similar prior reaction to same drug? | +1 | 0 | 0 |
| ADR confirmed by objective evidence? | +1 | 0 | 0 |

**Score interpretation:** ≥9 Definite, 5-8 Probable, 1-4 Possible, ≤0 Doubtful

CARE Checklist for Case Reports

Copy
## CARE (CAse REport) Guidelines Checklist

- [ ] Title: Diagnosis or intervention and type of case report
- [ ] Abstract: Structured with key information
- [ ] Introduction: Why this case is reportable
- [ ] Patient information: Demographics, medical history
- [ ] Clinical findings: Physical examination results
- [ ] Timeline: Key dates and events in chronological order
- [ ] Diagnostic assessment: Methods and reasoning
- [ ] Therapeutic intervention: What was done and rationale
- [ ] Follow-up and outcomes: Results and adherence
- [ ] Discussion: Strengths, limitations, relevant literature
- [ ] Patient perspective: When appropriate
- [ ] Informed consent: Documented

Configuration

Parameter	Description	Default
report_type	Case report, CSR, AE narrative	Required
citation_style	Vancouver, APA	vancouver
guideline	CARE, ICH E3, PRISMA	Based on report type
include_checklist	Append reporting checklist	true
de_identification	Auto-remove PHI markers	true

Best Practices

1. Follow established reporting guidelines. Use CARE for case reports, ICH E3 for clinical study reports, and PRISMA for systematic reviews. These frameworks ensure completeness and are required by most journals.

2. De-identify patient information rigorously. Remove or generalize all 18 HIPAA identifiers. Use age ranges instead of exact dates of birth, and replace hospital names with "[Institution]" if anonymity is required.

3. Include a timeline visualization. Chronological presentation of events is critical for clinical reports. A timeline table with dates, events, and assessments makes the clinical course immediately comprehensible to reviewers.

4. Use standardized causality assessment. For adverse event reports, always include a formal causality assessment (Naranjo, WHO-UMC) with the scoring rationale. Subjective assessments like "probably related" are insufficient for regulatory purposes.

5. Document informed consent. Every case report requires documented patient consent. Include a statement that the patient (or legal representative) provided informed consent for publication, and note any measures taken to ensure anonymity.

Common Issues

Report lacks sufficient clinical detail for peer review. Include all relevant lab values with reference ranges, imaging descriptions with radiological terminology, and treatment dosages with administration routes. Reviewers need enough detail to assess the clinical reasoning.

Timeline is unclear or contains inconsistencies. Map every clinical event to a specific date or day-relative-to-index-event. Use Day 0 for the inciting event and reference all subsequent events relative to that anchor. Cross-check that the narrative text matches the timeline table.

Causality assessment contradicts clinical evidence. Complete the Naranjo scale honestly — don't inflate scores to support a predetermined conclusion. If the score indicates "possible" rather than "probable," report it accurately and discuss the limitations.